BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement (“APA”) – PR Newswire
BioVaxys, a biotechnology company focused on developing innovative vaccines, has recently executed an amendment to its Asset Purchase Agreement (APA)…
Leggi tutto